Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for LDL-C in Primary Hypercholesterolemia
NCT00746811Phase 4Completed
- Sponsor
- Provident Clinical Research
- Start
- Jan 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in hypercholesterolemia (2 arms), sponsored by Provident Clinical Research. Primary endpoint: Percent Change From Baseline in LDL-C During Each Treatment. Started Jan 2010; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00746811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746811.